范碧娟 醫師
台大醫院 小兒神經科主治醫師
門診時間表 網路與現場掛號 加號加掛
台大醫院小兒神經科:
看診日期:週三下午、週五上午。
衛教文章
- 免切除大腦! 台大醫院首例微創手術救3歲癲癇女童 – 台大醫院小兒神經科醫師范碧娟表示,翁小妹1歲半以前發育正常,但約2歲時疑似單純性皰疹引發病毒性腦炎,就有持續性局部癲癇發作,原本藥物治療穩定,但今年變得難以控制,語言功能退化至1歲程度、吞嚥困難無法以口進食要借助鼻胃管,甚至幾乎全日臥床、意識不清。
- 睡覺突吼「我們都要死掉了」!7歲腦炎童手部出現奇怪姿勢 – 台大兒童醫院范碧娟醫師,也分享一位8個月大女嬰的腦炎個案,女童於5月4日出現嚴重發燒、食慾不佳、到院時PCR CT值14.9,女嬰的媽媽和外公都確診,評估後回家照顧,5月6日女童再度發燒至39.1℃,眼睛持續往左看,腦部CT有水腫,特別是左側較腫。
媒體報導訪問
【TSC整合門診十周年】
TSC 之神經系統表現與可能治療
來賓:台大兒童醫院小兒神經科主治醫師 范璧娟
Tuberous sclerosis complex (TSC) is a neurocutaneous syndrome characterized by early onset epilepsy, intellectual disability, autism and benign tumors, which can affect virtually any organ in the body such as skin, brain, kidneys, lung, and heart. Disease manifestations in different organ systems can vary widely between even closely related individuals which can make clinical diagnosis and treatment challenging. Dysfunction of the two causative genes, TSC1 and TSC2, which encode hamartin and tuberin respectively leads to hyperactivation of the mTOR and downstream signaling pathways, subsequently resulting in increased cell growth, proliferation, and abnormal gene expression. The treatment for TSC patients used to be symptom-oriented. Preclinical studies revealed the mTOR inhibitor reduces TSC-related tumors, including brain, skin, and kidney tumors, prevents epilepsy, increases survival, and reduces seizure frequency. Clinical studies also show that mTOR inhibitor therapy lead to regression of subependymal giant cell astrocytoma (SEGA), renal angiomyolipoma and pulmonary lymphangioleiomyomatosis as well as reduction of epilepsy. In this presentation, I will review the neurological features of TSC, emphasized on SEGA and epilepsy and how to treat, as well as brief the experiences in our multidisciplinary clinics.
來賓:台大兒童醫院兒童眼科主任 蔡紫薰
Tuberous sclerosis complex (TSC) is a neurocutaneous syndrome characterized by early onset epilepsy, intellectual disability, autism and benign tumors, which can affect virtually any organ in the body such as skin, brain, kidneys, lung, and heart. Disease manifestations in different organ systems can vary widely between even closely related individuals which can make clinical diagnosis and treatment challenging. Dysfunction of the two causative genes, TSC1 and TSC2, which encode hamartin and tuberin respectively leads to hyperactivation of the mTOR and downstream signaling pathways, subsequently resulting in increased cell growth, proliferation, and abnormal gene expression. The treatment for TSC patients used to be symptom-oriented. Preclinical studies revealed the mTOR inhibitor reduces TSC-related tumors, including brain, skin, and kidney tumors, prevents epilepsy, increases survival, and reduces seizure frequency. Clinical studies also show that mTOR inhibitor therapy lead to regression of subependymal giant cell astrocytoma (SEGA), renal angiomyolipoma and pulmonary lymphangioleiomyomatosis as well as reduction of epilepsy. In this presentation, I will review the neurological features of TSC, emphasized on SEGA and epilepsy and how to treat, as well as brief the experiences in our multidisciplinary clinics.
台醫網 AI 智能聊天
小兒神經纖維瘤之診斷與治療
來賓:台大兒童醫院小兒神經科主治醫師 范璧娟
2012年台灣神經纖維瘤協會年會暨醫療講座於5月5日於台大醫院舉辦。 由協會理事長 李銘仁 醫師主持,並邀請了台大醫院小兒科 范碧娟 醫師及臺北醫學大學 蔡翠敏 教授,為與會的朋友們進行醫療講座。 本篇是 范碧娟 醫師的[小兒神經纖維瘤之診斷與治療]講座。范醫師以其在臨床上豐富的小兒診療經驗,精譬的解說俾使朋友們更進一步瞭解NF的特性。 在此,協會感謝所有的與會的朋友,來賓及講師。協會感謝大家在幕前幕後的協助及支持,謝謝!
來賓:台大兒童醫院小兒神經科主治醫師 范璧娟
2012年台灣神經纖維瘤協會年會暨醫療講座於5月5日於台大醫院舉辦。 由協會理事長 李銘仁 醫師主持,並邀請了台大醫院小兒科 范碧娟 醫師及臺北醫學大學 蔡翠敏 教授,為與會的朋友們進行醫療講座。 本篇是 范碧娟 醫師的[小兒神經纖維瘤之診斷與治療]講座。范醫師以其在臨床上豐富的小兒診療經驗,精譬的解說俾使朋友們更進一步瞭解NF的特性。 在此,協會感謝所有的與會的朋友,來賓及講師。協會感謝大家在幕前幕後的協助及支持,謝謝!
本頁面內容來自親身經驗與網路公開資訊,非直接複製轉載自醫療機構,相關資料已導向原始來源。若有未盡完善之處敬請來信。
如果您覺得這篇文章有幫助
請點擊星星評分
平均評價 4.7 / 5. 評價數量: 3
成為第一個評分者